DE183712C - - Google Patents
Info
- Publication number
- DE183712C DE183712C DENDAT183712D DE183712DA DE183712C DE 183712 C DE183712 C DE 183712C DE NDAT183712 D DENDAT183712 D DE NDAT183712D DE 183712D A DE183712D A DE 183712DA DE 183712 C DE183712 C DE 183712C
- Authority
- DE
- Germany
- Prior art keywords
- blooded
- tubercle bacilli
- warm
- bacilli
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001465754 Metazoa Species 0.000 claims description 22
- 210000002966 serum Anatomy 0.000 claims description 20
- 201000008827 tuberculosis Diseases 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 2
- 244000052616 bacterial pathogen Species 0.000 claims 3
- 241000304886 Bacilli Species 0.000 description 37
- 241000700199 Cavia porcellus Species 0.000 description 14
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 12
- 241000270666 Testudines Species 0.000 description 9
- 229910052697 platinum Inorganic materials 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 241000270708 Testudinidae Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000700198 Cavia Species 0.000 description 2
- 241000270617 Cheloniidae Species 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 241000270322 Lepidosauria Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001444168 Natrix natrix Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000947840 Alteromonadales Species 0.000 description 1
- 241001464799 Anguis fragilis Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000826415 Psammobates geometricus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE183712C true DE183712C (enExample) |
Family
ID=447702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT183712D Active DE183712C (enExample) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE183712C (enExample) |
-
0
- DE DENDAT183712D patent/DE183712C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thomas et al. | The effect of cortisone on the Shwartzman reaction: The production of lesions resembling the dermal and generalized Shwartzman reactions by a single injection of bacterial toxin in cortisone-treated rabbits | |
| Apitz | A study of the generalized Shwartzman phenomenon | |
| EP0585552A1 (de) | Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura | |
| Flexner | The histological changes produced by ricin and abrin intoxications | |
| DE2547105A1 (de) | N-acetyl-muramyl-l-alanyl-d-isoglutamin enthaltende oelfreie adjuvanzien | |
| DE183712C (enExample) | ||
| Sonobe et al. | Silkworm Bombyx mori L.: Nature of diapause factor | |
| DE191752C (enExample) | ||
| DE69326347T2 (de) | Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt | |
| DE3524794A1 (de) | Pharmazeutisches praeparat enthaltend lebende vermehrungsfaehige embryonalzellen, verfahren zu dessen herstellung und testverfahren zur bestimmung der pharmazeutischen wirksamkeit | |
| DE1902590C2 (de) | Verwendung einer Immunribonucleinsäure (IRNS) zum Immunisieren lebender Tiere | |
| DE940315C (de) | Verfahren zur Herstellung von Lymphe gegen Schweinepest | |
| DE69032158T2 (de) | Wachstumsinhibitor von tumorzellen | |
| Bonventre et al. | An autoradiographic study of anthrax infection in the mouse | |
| DE2425678A1 (de) | Verfahren zur herstellung eines impfstoffs gegen infektioese pferdeanaemie | |
| DE238162C (enExample) | ||
| DE1617538C3 (de) | Verfahren zur Herstellung von Tetanus-Antitoxin | |
| DE2004869C2 (de) | Verwendung einer in üblicher Weise gewonnenen i-RNS zur Antikörper-Bildung | |
| Goodman | Observations on natural immunity and susceptibility to diphtheria toxin | |
| DE257473C (enExample) | ||
| Van Dyke et al. | A Study of the Standardization of Digitalis. II. The Relationship Between Laboratory Methods of Assay and Potency as Determined by Experimental Cumulative Poisoning and Clinical Standardization | |
| AT264713B (de) | Verfahren zur Herstellung von perkutan verwendbaren Dispersionen | |
| AT54778B (de) | Verfahren zur Gewinnung von Immunstoffen. | |
| Weichsel et al. | The Passage of Diphtheria Antitoxin into the Brain | |
| Ritchie | A review of current theories regarding immunity |